Andrei A Zamyatin

Title: Andrei A Zamyatin: Innovator in Pharmaceutical Science

Introduction

Andrei A Zamyatin is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative substances that target mitochondrial functions. His work is characterized by a commitment to advancing medical treatments through scientific research and innovation.

Latest Patents

Zamyatin holds a patent for pharmaceutical substances based on mitochondria-addressed antioxidants. The patent details purified pharmaceutical preparations comprising oxidized SkQ1, ensuring that no individual impurity exceeds 1.5%, the total impurity content does not exceed 4.0%, and the content of reduced SkQ1 is not greater than 10%. This innovative approach highlights the potential for improved therapeutic options in medicine.

Career Highlights

Throughout his career, Zamyatin has been associated with Mitotech SA, a company focused on developing mitochondrial-targeted therapies. His work has been instrumental in advancing the understanding of mitochondrial function and its implications for health and disease. Zamyatin's dedication to research has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Zamyatin has collaborated with esteemed colleagues, including Maxim Vladimirovich Skulachev and Vladimir Petrovich Skulachev. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.

Conclusion

Andrei A Zamyatin's contributions to pharmaceutical science through his innovative patents and collaborations underscore his importance in the field. His work continues to pave the way for advancements in medical treatments that target mitochondrial health.